Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials-Reference-Cited by-同舟云学术

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Published:2011-05-24 Issue:7 Volume:13 Page:615-628
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Leiter L. A.,Betteridge D. J.,Farnier M.,Guyton J. R.,Lin J.,Shah A.,Johnson-Levonas A. O.,Brudi P.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01383.x/fullpdf

Reference47 articles.

1. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.;Lloyd-Jones;Circulation,2006

2. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).;Pyorala;Diabetes Care,1997

3. Dyslipidemia in type 2 diabetes mellitus.;Mooradian;Nat Clin Pract Endocrinol Metab,2009

4. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23).;Turner;BMJ,1998

5. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.;Kearney;Lancet,2008

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Ezetimibe and Rosuvastatin: Impacts on Insulin Sensitivity and Vascular Inflammation in Patients with Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2024-01-31

2. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association;Circulation;2023-11-14

3. Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial;Journal of Atherosclerosis and Thrombosis;2023

4. Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid-Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus;Contemporary Diabetes;2023

5. Managing Stable Coronary Artery Disease in Diabetes;Diabetes and Cardiovascular Disease;2023